Our research
Tapscott Lab is part of Human Biology department at Fred Hutch, Seattle, Washington. The Lab focuses on gene transcription in a chromatin context in normal development and disease. The lab uses the myogenic transcription factor MyoD to study how complex programs of gene expression unfold during cell differentiation.
Team Tapscott
We have a great team consisting of staff scientists, postdoctoral research fellow, and technicians.
New publications
In October 2018, our multi-center collaboration through the Seattle Paul D. Wellstone Muscular Dystrophy Cooperative Research Center published a paper in Human Molecular Genetics: MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.
Friends of FSD research
The mission of Friends of FSH Research is to accelerate the discoveries that will lead to treatments or cures for FSHD. To achieve our goal, we actively manage a portfolio of research that supports a pipeline for drug discovery. Our board, staff, volunteers, and world-class scientists are fully committed to transparent, reproducible, and transformative science that will inspire hope for people with FSHD
Partners and collaborators
Fred Hutch Cancer Research Center partners with GlaxoSmithKline to develop muscular dystrophy therapeutics - The partnership with GSK is a first of its kind for Fred Hutch, which is also the first U.S.-based institution to sign on with GSK’s “Discovery Partnership with Academia” (DPAc) program.
Hope for FSHD patients
Hope for patients with a common muscular dystrophy - FSHD and other muscular dystrophies have proven to be extremely confounding for biomedical researchers, yielding so little information that the very idea of coming up with drugs to treat them has seemed like a dream.